Makers of billion-dollar drugs set to face their first U.S. price negotiations
Analysts expect Johnson & Johnson’s Xarelto blood thinner and Indianapolis-based Eli Lilly and Co.’s Jardiance for diabetes to be among the medications chosen.
Pharmaceutical
Articles
Lilly stock skyrockets, raising profile of city’s life sciences sector
The pharmaceutical company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer. In recent months, Lilly has overtaken every competitor to become the most valuable drugmaker in the world.
U.S eyes battle with drug giants over 10 costly medications for seniors
The list is expected to arrive within the next two weeks, and industry experts believe it will include some of the most widely prescribed treatments for arthritis, blood disorders, heart disease and diabetes.
Popular weight-loss drugs might raise risk of complications under anesthesia
Some anesthesiologists in the U.S. and Canada say they’ve seen growing numbers of patients on the weight-loss drugs who inhaled food and liquid into their lungs while sedated.
Supreme Court pauses Purdue Pharma $6 billion settlement plan
Thursday’s decision means settlement money meant for thousands of victims and their relatives and for local and state governments could be delayed.
Lilly stock soars to all-time high on strong sales, led by Mounjaro
Much of the excitement is due to strong results from Mounjaro, which hit the market in June 2022 as a treatment for Type 2 diabetes and rang up $979.7 million in the quarter.
Lilly reports surging profit, raises full-year guidance
The Indianapolis-based pharmaceutical company’s first-quarter performance was driven by strong sales of leading drugs for diabetes, cancer and other diseases.
IU Health’s new pharmacy hub aims to cut costs
Indiana University Health’s 70,000-square-foot pharmacy hub and distribution center in Plainfield has enough pills, lotions, and infusible and injectable drugs under one roof to supply its 16 hospitals and hundreds of clinics for weeks.
Tornado damage to Pfizer plant likely to cause long-term drug shortages
The fallout from a Pfizer factory being damaged by a tornado could put even more pressure on already-strained drug supplies at U.S. hospitals, experts say.
New research shows Lilly drug slows decline in Alzheimer’s patients
If U.S. regulators approve, the drug would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease—after rival Leqembi. Both drugs pose a serious safety concern—brain swelling and bleeding.
Alzheimer’s caregivers watching closely as drugs finally hit market
More than 110,000 Hoosiers suffer from Alzheimer’s disease, which robs people of their memories and abilities to do daily tasks, and is the nation’s sixth-leading cause of death.
Lilly to spend up to $1.93 billion to acquire Boston biopharmaceutical firm
With the acquisition of Versanis Bio, Lilly is adding another promising treatment to its weight-loss drug pipeline.
First over-the-counter birth control pill gets FDA approval
Women’s health advocates hope the decision will pave the way for more over-the-counter birth control options.
IBJ Podcast: Lilly in middle of big battle over future of drug prices for seniors
In this week’s edition of the IBJ Podcast, reporter John Russell discusses Medicare’s new power to negotiate drug prices and its effects on patients, drug makers and the rest the health care industry. Eli Lilly and Co. would like to see some changes.
Drugmakers warn new law will deter discoveries
David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.
Next step for obesity drug makers replacing needles with pills
Medical experts predict the pills will be popular, especially among people who want to lose weight but are fearful of needles.
Contract drugmaker Catalent shrinks as pandemic wanes
The New Jersey-based company has announced two large rounds of layoffs at its Bloomington plant within six months—400 workers last December and 150 this month.
Inflation Reduction Act foes race to repeal climate, drug pricing programs
A growing roster of corporate and political foes has started to lay siege to the law, hoping to erode some of its key provisions before they can take effect.
Indiana to receive $19M in opioid settlement funds this year
This year is the second year Indiana has received money from a national settlement with opioid distributors and manufacturers for opioid-related harms.
Insurers clamping down on doctors who prescribe Ozempic for weight loss
Indianapolis-based Elevance Health, which operates Anthem plans, said that in most cases, it won’t cover Ozempic unless a patient is diagnosed with diabetes and has tried another medication to manage it, but physicians can still prescribe it.